Abattis Bioceuticals Corp.
ATTBF
Rank in Stocks
#35227
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology... Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Share Price
$0.000001
Last synced: 2026-11-09
Market Cap
$477.88
Change (1 day)
-96.67%
Change (1 year)
-96.67%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Abattis Bioceuticals Corp. (ATTBF)
Category
Healthcare
Operating Margin for Abattis Bioceuticals Corp. (ATTBF)
Operating Margin as of November 2026 TTM: -1,108.73%
According to Abattis Bioceuticals Corp.'s latest financial reports, its current operating margin (TTM) is -1,108.73%. At the end of 2019 the company had an operating margin of -1,108.73%.
Operating Margin history for Abattis Bioceuticals Corp. from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -1,108.73% | 0.00% |
| 2019 | -1,108.73% | -99.47% |
| 2018 | -207,542.23% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | -3,347.57% | -96.49% |
| 2014 | -95,292.85% | 1,514.51% |
| 2013 | -5,902.26% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 62.34% | -100.06% |
US
|
|
| 31.60% | -100.03% |
SE
|
|
| 30.13% | -100.03% |
FR
|
|
| 29.76% | -100.03% |
HK
|
|
| 30.46% | -100.03% |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Abattis Bioceuticals Corp.'s operating margin
What is Abattis Bioceuticals Corp.'s operating margin?
Abattis Bioceuticals Corp.'s operating margin is -1,108.73%, as of Nov 2026.
What was Abattis Bioceuticals Corp.'s operating margin in 2019?
In 2019, Abattis Bioceuticals Corp.'s operating margin was -1,108.73%, compared with -207,542.23% in 2018.
How has Abattis Bioceuticals Corp.'s operating margin changed since 2014?
From 2014 to 2019, Abattis Bioceuticals Corp.'s operating margin was highest in 2017 (0.00%) and lowest in 2018 (-207,542.23%).
How does Abattis Bioceuticals Corp.'s operating margin compare with similar companies?
Abattis Bioceuticals Corp.'s operating margin (-1,108.73%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 62.34%.